Pax8 immunostaining of a thyroid mass distinguishes metastatic lung cancer from anaplastic thyroid cancer
Publication
, Conference
Kelley, CE; Setji, TL; Shattuck, T; Moss, LG
June 2013
Duke Scholars
Publication Date
June 2013
Location
San Francisco, CA
Conference Name
Endocrine Society Annual Meeting
Citation
APA
Chicago
ICMJE
MLA
NLM
Kelley, C. E., Setji, T. L., Shattuck, T., & Moss, L. G. (2013). Pax8 immunostaining of a thyroid mass distinguishes metastatic lung cancer from anaplastic thyroid cancer. Presented at the Endocrine Society Annual Meeting, San Francisco, CA.
Kelley, C. E., T. L. Setji, T. Shattuck, and L. G. Moss. “Pax8 immunostaining of a thyroid mass distinguishes metastatic lung cancer from anaplastic thyroid cancer,” 2013.
Kelley CE, Setji TL, Shattuck T, Moss LG. Pax8 immunostaining of a thyroid mass distinguishes metastatic lung cancer from anaplastic thyroid cancer. In 2013.
Kelley, C. E., et al. Pax8 immunostaining of a thyroid mass distinguishes metastatic lung cancer from anaplastic thyroid cancer. 2013.
Kelley CE, Setji TL, Shattuck T, Moss LG. Pax8 immunostaining of a thyroid mass distinguishes metastatic lung cancer from anaplastic thyroid cancer. 2013.
Publication Date
June 2013
Location
San Francisco, CA
Conference Name
Endocrine Society Annual Meeting